Teva Pharmaceutical Industries Ltd. (TEVA)
38.90
-0.24
(-0.60%)
USD |
NYSE |
Oct 07, 10:05
Teva Pharmaceutical Industries Price : 38.90 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 39.65 | 39.93 | 38.85 | 39.13 | 5.717M |
| Oct 05, 2026 | 39.44 | 40.03 | 39.27 | 39.66 | 4.148M |
| Oct 02, 2026 | 39.31 | 39.81 | 39.05 | 39.53 | 4.775M |
| Oct 01, 2026 | 39.50 | 39.58 | 38.52 | 39.31 | 5.987M |
| Sep 30, 2026 | 40.20 | 40.28 | 39.22 | 39.60 | 5.655M |
| Sep 29, 2026 | 38.90 | 40.24 | 38.66 | 39.81 | 6.823M |
| Sep 28, 2026 | 38.36 | 39.11 | 38.30 | 38.88 | 4.307M |
| Sep 25, 2026 | 40.10 | 40.25 | 38.93 | 39.19 | 3.875M |
| Sep 24, 2026 | 38.74 | 40.31 | 38.63 | 40.22 | 7.732M |
| Sep 23, 2026 | 39.68 | 40.09 | 38.92 | 39.01 | 6.139M |
| Sep 22, 2026 | 39.45 | 40.14 | 39.05 | 39.52 | 4.543M |
| Sep 21, 2026 | 39.09 | 40.79 | 38.36 | 40.06 | 5.942M |
| Sep 18, 2026 | 38.90 | 39.38 | 38.66 | 38.98 | 5.477M |
| Sep 17, 2026 | 38.96 | 39.70 | 38.71 | 39.19 | 5.521M |
| Sep 16, 2026 | 39.02 | 39.52 | 38.32 | 38.53 | 4.822M |
| Sep 15, 2026 | 38.71 | 39.49 | 38.11 | 39.25 | 7.128M |
| Sep 14, 2026 | 37.66 | 39.22 | 37.00 | 38.72 | 4.382M |
| Sep 11, 2026 | 37.00 | 37.00 | 37.00 | 37.00 | 5.000 |
| Sep 10, 2026 | 36.37 | 36.75 | 36.04 | 36.35 | 4.014M |
| Sep 09, 2026 | 36.82 | 37.32 | 36.47 | 36.85 | 4.000M |
| Sep 08, 2026 | 35.89 | 36.96 | 35.42 | 36.76 | 4.624M |
| Sep 04, 2026 | 36.40 | 36.93 | 36.13 | 36.36 | 7.403M |
| Sep 03, 2026 | 37.98 | 38.06 | 36.33 | 36.62 | 3.905M |
| Sep 02, 2026 | 36.65 | 37.59 | 35.74 | 37.49 | 7.690M |
| Sep 01, 2026 | 36.52 | 36.55 | 35.85 | 36.19 | 3.516M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1181.77 |
| Bristol Myers Squibb Co. | 59.68 |
| Merck & Co., Inc. | 143.07 |
| RedHill Biopharma Ltd. | 0.4778 |
| Johnson & Johnson | 259.36 |
Price Related Metrics
| PE Ratio | 65.40 |
| PS Ratio | 2.608 |
| Price to Book Value | 5.845 |
| Price to Free Cash Flow | 30.99 |
| Earnings Yield | 1.53% |
| Market Cap | 45.31B |
| Operating PE Ratio | 13.88 |
| Normalized PE Ratio | 24.50 |